Founder-led Biotech on Tour
LONDON
London, England
Join Pillar VC and co-hosts for the London stop of the Founder-led Biotech Tour. This event is a curated evening of networking with founders, PhD students and leaders of the founder-led biotech movement.
London Co-hosts
Simon
Kohl
Jen
Keane
Andy
Heron
James
Bayne et al
Laksh
Aithani
Ben
Reeve
Glen
Gowers
William
Pelton
Nick
Kral
Jack
O'Meara
Ignacio
Willats
Alon
Galor
Francois Vigneault
Max
Jamilly
Sam
Rodriques
Virtual Events
Virtual events are open registration. You’ll need to register for each event separately.
DAY 1
Virtual speed networking
Rapid 2-minute chats with other attendees, fostering quick yet impactful connections from wherever you are. Register
DAY 2
Virtual co-founder match
Dive into curated conversations on the Hopin platform. Discover your next startup collaborator. Register
DAY 3
Virtual speed networking
Rapid 2-minute chats with other attendees, fostering quick yet impactful connections from wherever you are. Register
Want to get involved?
If you have a concept for a virtual event that aligns with our mission, we want to hear from you! Whether it’s a workshop, panel discussion, or a unique interactive session, share your vision with us, and let’s bring it to life together.
Email madelyn@pillar.vc
London Co-hosts
Alon
Galor
Laksh
Aithani
Glen
Gowers
William
Pelton
Phytoform is a US/UK biotech that believes to make our food supply chain sustainable, crop genetics is the answer. Phytoform has developed a platform leveraging AI and genome editing to rapidly identify and deliver genetic solutions that significantly reduce waste and inputs throughout the food supply chain. We are focused on delivering value across traits, crops and geographies to reduce the impact of agriculture.
Nick
Kral
Phytoform is a US/UK biotech that believes to make our food supply chain sustainable, crop genetics is the answer. Phytoform has developed a platform leveraging AI and genome editing to rapidly identify and deliver genetic solutions that significantly reduce waste and inputs throughout the food supply chain. We are focused on delivering value across traits, crops and geographies to reduce the impact of agriculture.
Andrew
Heron
Portal’s mission is to provide scientists and clinicians with fundamental tools to understand proteins and metabolites, enabling ground-breaking discoveries in health and biology, and expediting bringing new drugs and treatments to market.
Max
Jamilly
At Hoxton Farms, we are cultivating a delicious fatty future. We grow real animal fat – without the animals – to make meat alternatives that look, cook and taste like the real thing. Cofounded in 2020 by Max Jamilly and Ed Steele, we are a team of 45 based in London, building the world’s most scalable and cost-effective platform for mammalian cell biomanufacturing. Our investors include Founders Fund, Collab Fund, FSV/F-Prime and Global Brain.
Ed
Steele
At Hoxton Farms, we are cultivating a delicious fatty future. We grow real animal fat – without the animals – to make meat alternatives that look, cook and taste like the real thing. Cofounded in 2020 by Max Jamilly and Ed Steele, we are a team of 45 based in London, building the world’s most scalable and cost-effective platform for mammalian cell biomanufacturing. Our investors include Founders Fund, Collab Fund, FSV/F-Prime and Global Brain.
Jessica
Corry
Xterna is a founder-led pre-seed biotech, leveraging cutting edge XNA technologies to engineer next generation drug delivery solutions for currently undruggable cell types.
Ignacio
Willats
Mytos automates one of the last highly manual processes in biotech – growing human cells. Our products help teams in drug development and cell therapy save time while increasing the reproducibility of their data. Mytos is backed by a fleet of leading investors including YCombinator. Our team is made up of brilliant engineers from Dyson, Formlabs and Cambridge Consultants and driven scientists who have worked in top labs including at Imperial College, University of Cambridge and UCL.
Ali
Afshar
Mytos automates one of the last highly manual processes in biotech – growing human cells. Our products help teams in drug development and cell therapy save time while increasing the reproducibility of their data. Mytos is backed by a fleet of leading investors including YCombinator. Our team is made up of brilliant engineers from Dyson, Formlabs and Cambridge Consultants and driven scientists who have worked in top labs including at Imperial College, University of Cambridge and UCL.
Max
Doody
Ben
Reeve
Modern Synthesis is a London-based biotech company bringing life to new materials. We work with bacteria to produce an entirely new class of nanocellulose-based materials which offer performance without plastics and aesthetics without animal inputs, designed for applications within fashion and beyond.
Jen
Keane
Modern Synthesis is a London-based biotech company bringing life to new materials. We work with bacteria to produce an entirely new class of nanocellulose-based materials which offer performance without plastics and aesthetics without animal inputs, designed for applications within fashion and beyond.
Simon
Kohl
Giovanni
Maglia
Portal is revolutionising biosensing by bringing precise and universal proteomics and metabolomics to the bench-top. Proteins are the functional unit of biology, involved in every pathway and reaction, every synthesis and chemical modification, that make life possible.
Miroslav
Gasparek
Sensible accelerates the development of the next generation of mRNA medicines by design, optimisation and cell-based manufacturing of non-immunogenic, pure, and highly functional mRNA in a scalable and cost-effective way.
